Laboratory Automation Systems to Pave the Way for Clinical Laboratories’ Future

21 May 2018

The laboratory automation industry consists of a large number of companies, which are manufacturing systems and components as well as software to meet the rising demands for laboratory automation system.   According to the latest market intelligence report by BIS Research titled, ‘Global Laboratory Automation Systems Market- Analysis and Forecast (2017-2026), the market for laboratory automation systems is anticipated to reach $9.55 billion by 2026. The prominent market players who play a significant role in the market for laboratory automation systems are Agilent Technologies Inc., Apricot Designs, Becton, Dickinson and Company, Tecan Group Ltd., and Thermo Fisher Scientific, among others.   

In May 2018, Agilent Technologies Inc., acquired privately held Genohm, a developer of highly differentiated, on-premise and cloud-based software solutions for laboratory management. This acquisition will allow Agilent to bring greater context to analytical data, enabling scientists to generate the results more efficiently. “We are very excited to join the Agilent team and believe that together we can accelerate development of the digital lab to help our customers advance science and discovery while ensuring compliance and traceability,” said Frederik Decouttere, Founder, and CEO of Genohm.             

In April 2018, BD (Becton, Dickinson, and Company), a leading global medical technology company, introduced various new informatics and automation solutions for clinical laboratories. The proposed solutions play a critical role against the infectious diseases and antimicrobial resistance. The company announced their plan for the commercial availability of BD Synapses TM microbiology informatics solution, which provides laboratories with secure connectivity across instruments and locations.1

In April 2018, Sanquin and Abbott Laboratories announced their contract for the supply of primary serological equipment and consumables, including Abbott’s AlinityTM, a system for blood and plasma screening. In the services provided by both the companies, there is a differentiation in assay performance, footprint efficiency, and ease of use which help in optimizations of laboratory operations. The Alinity solutions’ objective is to meet the accuracy and efficiency needs of blood and plasma screening customers around the world.2

The global market for laboratory automation system can be segmented by product types, software types, applications specific, and end-user industries. Among the product types, automation system dominated the market for laboratory automation in 2016. At present, the pharmaceutical, bio-pharmaceutical industries, and Contact Research Organizations (CRO) contribute to the largest share of laboratory automation systems’ market. The pharma and Biopharmaceutical Industry is expected to register the highest CAGR of 6.71% from 2017-2026.    


  1. News Medical
  2. Select Science

Twitter Feeds